A First-in-Human Safety Trial of MTX-463

NCT06401213 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mediar Therapeutics

Collaborators